S2398-119

Passed Senate

Kay Hagan Tick Reauthorization Act

119th Congress Introduced Jul 23, 2025

Summary

What This Bill Does

The Kay Hagan Tick Reauthorization Act extends two Public Health Service Act authorization periods from fiscal years 2021 through 2025 to fiscal years 2026 through 2030. For the section 317U tick-borne disease program, it replaces a required reference to the former Tick-Borne Disease Working Group and other individuals with the more flexible phrase 'appropriate individuals.' It also changes the program's administrative language from acting 'in coordination with' an official to acting 'through' that official. A related authorization in section 2822(c), concerning public-health preparedness, is extended through 2030 as well. The bill preserves program authority but does not itself specify annual appropriation amounts.

Who Benefits and How

Patients with Lyme disease and other tick-borne illnesses benefit from continued federal surveillance, prevention, research, and coordination authority. State and local health departments, clinicians, and researchers may continue participating in federally supported disease detection and response work. Preparedness programs gain five additional authorized fiscal years.

Who Bears the Burden and How

HHS and CDC program staff must administer the authorities through 2030 and adapt consultation and chain-of-command practices to the revised language. Federal taxpayers may fund continued activities through later appropriations. Congressional health committees retain oversight of program performance over the extended period.

Key Provisions

  • Extends the section 317U tick-borne disease authorization through fiscal year 2030.
  • Modifies consultation language to refer broadly to appropriate individuals.
  • Requires the Secretary to act through the specified public-health official.
  • Extends the related section 2822(c) preparedness authorization through fiscal year 2030.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Reauthorizes federal tick-borne disease and related public-health preparedness authorities for fiscal years 2026 through 2030 and updates program administration.

Key Policy Areas

Public Health, Infectious Disease, Health Preparedness

Primary Purpose

Reauthorizes federal tick-borne disease and related public-health preparedness authorities for fiscal years 2026 through 2030 and updates program administration.

Policy Domains

Public Health Infectious Disease Health Preparedness

Kay Hagan Tick Reauthorization Act

Identified Gains
  • Patients with tick-borne diseases
  • State health departments
  • Tick-borne disease researchers
  • Public-health preparedness programs
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: es
State health departments: ,
Tick-borne disease researchers: ,
Patients with tick-borne diseases: ,
Public-health preparedness programs: ,
Identified Costs
  • HHS public-health officials
  • CDC program staff
  • Federal taxpayers
  • Congressional health committees
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: es
CDC program staff: ,
Federal taxpayers: ,
HHS public-health officials: ,
Congressional health committees: ,

Legislative Progress

Passed Senate
Introduced Committee Passed
Aug 10, 2026

Held at the desk.

Aug 10, 2026

Received in the House.

Aug 10, 2026

Message on Senate action sent to the House.

Aug 6, 2026

Passed Senate with an amendment by Voice Vote. (consideration: CR …

Aug 6, 2026

Passed/agreed to in Senate: Passed Senate with an amendment by …

Sep 8, 2025

Reported by Mr. Cassidy, with an amendment

Sep 8, 2025

Placed on Senate Legislative Calendar under General Orders. Calendar No. …

Sep 8, 2025

Committee on Health, Education, Labor, and Pensions. Reported by Senator …

Jul 30, 2025

Committee on Health, Education, Labor, and Pensions. Ordered to be …

Jul 23, 2025

Ms. Collins (for herself, Ms. Smith, Mr. King, Mrs. Gillibrand, …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
9 mentions across 5 clauses
+2 positive -3 negative ?4 uncertain

CDC program staff, Federal legislative records staff, HHS public-health officials

Positive-direction: State health departments

Negative-direction: CDC program staff, HHS public-health officials

General Public
4 mentions across 3 clauses
+2 positive -1 negative ?1 uncertain

Patients with tick-borne diseases, Taxpayers

Positive-direction: Patients with tick-borne diseases

Negative-direction: Taxpayers

Professional Services
2 mentions across 2 clauses
?2 uncertain

Legislative compliance counsel

Healthcare
1 mention across 1 clause
+1 positive

Tick-borne disease researchers

2/4
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Public Health Infectious Disease Health Preparedness
Actor Mappings
"partners"
→ State health departments and appropriate individuals
"administrator"
→ Secretary of Health and Human Services
"program_staff"
→ Centers for Disease Control and Prevention
"affected_public"
→ Patients with tick-borne diseases

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology